Analysis of Medtronic share price

67% of retail investor accounts lose money when trading CFDs with this provider.
Chart provided by Tradingview

If you plan to buy Medtronic shares online in the near future using a trading platform then before starting to prepare your analyses on this asset we recommend you read this detailed article with advice and information that will be useful to you. You will notably find details relating to this company, its activities, a historical analysis of its share price and its real time share price.

Elements that can influence the price of this asset:

Analysis N°1

We would particularly follow the launch of new products that enable Medtronic to position itself in new markets.

Analysis N°2

Any merger or acquisition operations are of course also extremely significant as they would enable the group to gain a strategic advantage against its major competitors.

Analysis N°3

We would also carefully monitor any investments made by Medtronic in the area of research and development relating to the improvement of its technologies and capabilities.

Analysis N°4

The fact that Medtronic primarily exercises its activities on the more mature markets means that it would also be prudent to monitor the efforts made that enable an expansion of this group on an international level, notably in the emerging markets.

Analysis N°5

The political risk is also an element that should be carefully considered relating to the future of Medtronic. Governmental interventions and regulations can impact the profitability of this company and should therefore be carefully monitored.

Analysis N°6

Finally, we would also carefully monitor the foreign exchange market as movements in the exchange rates will have a direct impact on this company’s profitability relating to sales and exports as well as production costs.

67% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on eToro

General presentation of Medtronic

The Medtronic Group is one of the largest designers, manufacturers and sellers of medical equipment and devices worldwide. It notably provides cardiac pacemakers, vascular treatment devices, items for spinal problems and neurological problems as well as the management of diabetes and cardiac surgery.

Medtronic achieves the largest part of its turnover in the United States but it is also present in Europe, Canada, Pacific Asia and other areas around the world.

To understand the range of challenges that affect the Medtronic Company and its position in the medical appliances sector, we now offer you the opportunity to learn about the items produced by this group, those that are the most popular and those that create the highest turnover for this company:

  • Cardiac stimulators or pacemakers with over 3 million devices sold up to now.
  • Cardiac defibrillators.
  • Stents, also used in cardiac surgery.
  • Heart valves.
  • Neuronal stimulators notably used for the detection and treatment of neurodegenerative illnesses.
  • Spinal disc replacement prostheses generally used worldwide.
  • Glucometers used to measure the amount of sugar in the blood, notably for patients diagnosed with diabetes.
  • Automatic injectors mainly used in hospital environments.
  • Coronary and vascular prostheses, also called stents even though the shape is slightly different.
Analysis of Medtronic share price
67% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on eToro

The major competitors of Medtronic

The Medtronic Company is currently one of the most innovative in terms of medical technology. It actually holds second position worldwide in a classification of companies in this sector in terms of turnover, just behind its direct competitor Johnson & Johnson.  But this is not the only competitor that needs to be taken into account during your analyses. In fact, other companies of intermediate size as well as larger companies should also be monitored as they could take part of Medtronic’s market share depending on their future innovations. We therefore offer you the opportunity to learn more on this subject.   

General Electric, Siemens and Philips are the most serious competitors to the Medtronic Group. However, we would also recommend you monitor other companies including Cardinal Health, Danaher, Becton Dickenson, Baxter International, Stryker, Abbott, Boston Scientific, Essilor, Braun, Novartis, Zimmer and Fresenius.

We also urge you to follow all news and events relating to technological innovations from these companies that could lead to a rapid rise in their profits.

The major partners of Medtronic

To conclude, here are the current major partners of Medtronic with details on the agreements implemented by this group.


In 2015, the IBM Group created a platform entitled Watson Health for the centralisation of health data from Apple terminals and from its partners such as Medtronic and Johnson & Johnson.


In 2016, Medtech, which created a revolutionary imaging system, signed an agreement with Medtronic aimed at using the sales strengths of the latter for marketing this French firm’s device, notably on the Japanese market.

Groupe Roche

In 2017, the Roche Group also implemented a partnership with Medtronic with the objective of developing a glycaemia indicator that functioned with bluetooth and was connected to an insulin pump system from Medtronic.

67% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on eToro
The factors in favour of a rise in the Medtronic share price:

To effectively analyse the Medtronic share price you will need to understand the way in which investors see this asset.  For this the ideal way is to compare the strengths and weaknesses of this company. Let us begin by examining its major advantages.

Firstly, the activity sector in which Medtronic exercises its activities is clearly one of the sectors that has experienced rapid success. This achievement coupled with the fact that the competition is fairly weak in this sector means we can expect to see this group’s income increase in the future.

Also, the Medtronic Company benefits from a strong brand name that is renowned among its clients and prospects around the world. This brand image has been built upon the ability of Medtronic to use technology and effectively benefit from its creativity from its beginning through to now. The Medtronic brand is therefore often associated with the idea of innovation and technological advances.

Another strong point of this company we can mention is the fact that its supply chain is particularly solid and reliable with loyal regular partners. In this way Medtronic is able to effectively respond to demand even if this should experience a significant increase.

Finally, the financial stability of this group is also one of its strong points most appreciated by the traders and analysts particularly due to the fact that this company is capable of achieving savings through its large volume production capabilities which significantly reduce costs.

The factors in favour of a drop in the Medtronic share price:

Of course, before taking position on the rise on the Medtronic share price you should also evaluate the weak points of this company and take them into account when completing your analyses. Here therefore are details of the major disadvantages and weak points of this company:

  • Firstly, although the financial situation of this group is relatively positive we note a certain instability in its performance over the years that makes it difficult to anticipate future profits.
  • We also note some difficulties encountered by Medtronic in the past with certain partners that could reoccur with negative consequences for its growth and profitability.
  • To conclude, purely relating to the financial data of this group we also notice the overall disappointing results relating to the gross margin, the operating margin and the net margin compared to other industries in the same sector of activity, despite the advances made with cost reduction.
The information supplied here is only for indicative purposes and should not be used without the completion of a comprehensive and complete fundamental analysis of this asset notably taking into account exterior data, future publications and announcements and all fundamental events and news that could influence the strengths and weaknesses or make them more or less significant. This information does not in any way constitute recommendations relating to the completion of transactions.

eToro is a multi-asset platform offering both equity as well as asset trading in the form of CFDs.

Please note that CFDs are complex instruments and present a high risk of rapid loss of funds due to their leverage effect. 67% of retail traders' accounts lose funds when trading CFDs with this supplier. You should ask yourself if you understand how CFDs work and if you can afford to take the significant risk of losing your money.

The content in question is provided for information purposes only and should not be considered as investment advice. Past performance is no guarantee of future results. The trading history is less than 5 years old and may not be sufficient to serve as a basis for an investment decision.

Crypto-actives are volatile instruments that can fluctuate considerably over a very short period of time and are therefore not suitable for all investors. Other than through CFDs, crypto-active trading is not regulated by any EU regulatory framework and is therefore not supervised. This is an advert for trading CFDs on eToro